Literature DB >> 34260264

β-Catenin Restricts Zika Virus Internalization by Downregulating Axl.

Oscar A Jimenez1, Srinivas D Narasipura1, Hannah J Barbian1, Yasmeen A Albalawi1, Melanie S Seaton1, KaReisha F Robinson1, Lena Al-Harthi1.   

Abstract

The latest outbreak of Zika virus (ZIKV) in the Americas was associated with significant neurologic complications, including microcephaly of newborns. We evaluated mechanisms that regulate ZIKV entry into human fetal astrocytes (HFAs). Astrocytes are key players in maintaining brain homeostasis. We show that the central mediator of canonical Wnt signaling, β-catenin, regulates Axl, a receptor for ZIKV infection of HFAs, at the transcriptional level. In turn, ZIKV inhibited β-catenin, potentially as a mechanism to overcome its restriction of ZIKV internalization through regulation of Axl. This was evident with three ZIKV strains tested but not with a laboratory-adapted strain which has a large deletion in its envelope gene. Finally, we show that β-catenin-mediated Axl-dependent internalization of ZIKV may be of increased importance for brain cells, as it regulated ZIKV infection of astrocytes and human brain microvascular cells but not kidney epithelial (Vero) cells. Collectively, our studies reveal a role for β-catenin in ZIKV infection and highlight a dynamic interplay between ZIKV and β-catenin to modulate ZIKV entry into susceptible target cells. IMPORTANCE ZIKV is an emerging pathogen with sporadic outbreaks throughout the world. The most recent outbreak in North America was associated with small brains (microcephaly) in newborns. We studied the mechanism(s) that may regulate ZIKV entry into astrocytes. Astrocytes are a critical resident brain cell population with diverse functions that maintain brain homeostasis, including neurogenesis and neuronal survival. We show that three ZIKV strains (and not a heavily laboratory-adapted strain with a large deletion in its envelope gene) require Axl for internalization. Most importantly, we show that β-catenin, the central mediator of canonical Wnt signaling, negatively regulates Axl at the transcriptional level to prevent ZIKV internalization into human fetal astrocytes. To overcome this restriction, ZIKV downregulates β-catenin to facilitate Axl expression. This highlights a dynamic host-virus interaction whereby ZIKV inhibits β-catenin to promote its internalization into human fetal astrocytes through the induction of Axl.

Entities:  

Keywords:  Axl; TCF4; Tyro3; Wnt signaling; ZIKV; Zika; astrocytes; brain; flavivirus; infection; internalization; β-catenin

Mesh:

Substances:

Year:  2021        PMID: 34260264      PMCID: PMC8354222          DOI: 10.1128/JVI.00705-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Zika virus. I. Isolations and serological specificity.

Authors:  G W A DICK; S F KITCHEN; A J HADDOW
Journal:  Trans R Soc Trop Med Hyg       Date:  1952-09       Impact factor: 2.184

2.  Stabilized beta-catenin extends thymocyte survival by up-regulating Bcl-xL.

Authors:  Huimin Xie; Zhaofeng Huang; Maureen S Sadim; Zuoming Sun
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

3.  AXL-dependent infection of human fetal endothelial cells distinguishes Zika virus from other pathogenic flaviviruses.

Authors:  Audrey Stéphanie Richard; Byoung-Shik Shim; Young-Chan Kwon; Rong Zhang; Yuka Otsuka; Kimberly Schmitt; Fatma Berri; Michael S Diamond; Hyeryun Choe
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-06       Impact factor: 11.205

4.  Zika virus cell tropism in the developing human brain and inhibition by azithromycin.

Authors:  Hanna Retallack; Elizabeth Di Lullo; Carolina Arias; Kristeene A Knopp; Matthew T Laurie; Carmen Sandoval-Espinosa; Walter R Mancia Leon; Robert Krencik; Erik M Ullian; Julien Spatazza; Alex A Pollen; Caleigh Mandel-Brehm; Tomasz J Nowakowski; Arnold R Kriegstein; Joseph L DeRisi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-29       Impact factor: 11.205

Review 5.  Interplay between Wnt/β-catenin signaling and HIV: virologic and biologic consequences in the CNS.

Authors:  Lena Al-Harthi
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-13       Impact factor: 4.147

6.  Human immunodeficiency virus type 1 (HIV-1) transactivator of transcription through its intact core and cysteine-rich domains inhibits Wnt/β-catenin signaling in astrocytes: relevance to HIV neuropathogenesis.

Authors:  Lisa J Henderson; Amit Sharma; Maria Chiara G Monaco; Eugene O Major; Lena Al-Harthi
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

7.  Expression Analysis Highlights AXL as a Candidate Zika Virus Entry Receptor in Neural Stem Cells.

Authors:  Tomasz J Nowakowski; Alex A Pollen; Elizabeth Di Lullo; Carmen Sandoval-Espinosa; Marina Bershteyn; Arnold R Kriegstein
Journal:  Cell Stem Cell       Date:  2016-03-30       Impact factor: 24.633

8.  Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.

Authors:  Cheril Tapia-Rojas; Nibaldo C Inestrosa
Journal:  J Neurochem       Date:  2018-01-26       Impact factor: 5.372

9.  N-Methyl-d-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by Zika Virus Infection.

Authors:  Vivian V Costa; Juliana L Del Sarto; Rebeca F Rocha; Flavia R Silva; Juliana G Doria; Isabella G Olmo; Rafael E Marques; Celso M Queiroz-Junior; Giselle Foureaux; Julia Maria S Araújo; Allysson Cramer; Ana Luíza C V Real; Lucas S Ribeiro; Silvia I Sardi; Anderson J Ferreira; Fabiana S Machado; Antônio C de Oliveira; Antônio L Teixeira; Helder I Nakaya; Danielle G Souza; Fabiola M Ribeiro; Mauro M Teixeira
Journal:  MBio       Date:  2017-04-25       Impact factor: 7.867

10.  β-Catenin signaling positively regulates glutamate uptake and metabolism in astrocytes.

Authors:  Victoria Lutgen; Srinivas D Narasipura; Amit Sharma; Stephanie Min; Lena Al-Harthi
Journal:  J Neuroinflammation       Date:  2016-09-10       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.